https://www.pharmaradar360.com/article/built-different-the-case-for-specialized-humanoids-63c54db704a98463Pharma Surgeen2026-06-21T15:31:58.000ZBuilt Different: The Case for Specialized Humanoidshttps://www.pharmaradar360.com/article/long-lived-families-reveal-a-rare-genetic-clue-to-healthy-aging-d621bcebd8ce5086Pharma Surgeen2026-06-21T14:57:42.000ZLong-lived families reveal a rare genetic clue to healthy aginghttps://www.pharmaradar360.com/article/tubulin-prevents-toxic-brain-protein-clumps-linked-to-alzheimer-s-and-parkinson-ea613fc4792fea2dPharma Surgeen2026-06-21T13:08:10.000ZTubulin prevents toxic brain protein clumps linked to Alzheimer’s and Parkinson’shttps://www.pharmaradar360.com/article/yale-study-finds-nearly-half-of-older-adults-improved-with-age-6c6d331c4d824a09Pharma Surgeen2026-06-21T10:02:10.000ZYale study finds nearly half of older adults improved with agehttps://www.pharmaradar360.com/article/nhsggc-team-provides-vital-skin-cancer-support-as-demand-grows-4ea9e1b316c836fdPharma Surgeen2026-06-21T08:30:00.000ZNHSGGC team provides vital skin cancer support as demand growshttps://www.pharmaradar360.com/article/scientists-discover-neurons-must-break-their-dna-to-build-the-brain-8ed705383cda1371Pharma Surgeen2026-06-21T06:30:35.000ZScientists discover neurons must break their DNA to build the brainhttps://www.pharmaradar360.com/article/major-review-finds-vaping-likely-causes-lung-and-oral-cancer-a62ed56320212583Pharma Surgeen2026-06-21T05:26:23.000ZMajor review finds vaping likely causes lung and oral cancerhttps://www.pharmaradar360.com/article/natco-records-e2-82-b9816-9-crore-consolidated-revenue-and-e2-82-b9269-0-crore-o-86a10dd1d2ffb4bbPharma Surgeen2026-06-21T00:00:00.000Znatco records %e2%82%b9816 9 crore consolidated revenue and %e2%82%b9269 0 crore of profit after tax for q4 fy26 and %e2%82%b94375 9 crore of revenue %e2%82%b91418 5 crore profit after tax for fy26https://www.pharmaradar360.com/article/natco-records-e2-82-b9705-4-crore-consolidated-revenue-and-e2-82-b9151-3-crore-o-a55687508ccb379bPharma Surgeen2026-06-21T00:00:00.000Znatco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26https://www.pharmaradar360.com/article/natco-records-e2-82-b91463-crore-consolidated-revenue-and-e2-82-b9517-9-crore-of-aafed9d696a6baeePharma Surgeen2026-06-21T00:00:00.000Znatco records %e2%82%b91463 crore consolidated revenue and %e2%82%b9517 9 crore of profit after tax for q2fy26https://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-erdafitinib-tablets-generic-of-balversa-fr-1e9530d59e719c89Pharma Surgeen2026-06-21T00:00:00.000Znatco receives tentative approval for erdafitinib tablets generic of balversa from the united states food and drug administration u s fdahttps://www.pharmaradar360.com/article/natco-receives-approval-from-central-drug-standard-control-organisation-cdsco-fo-7316ad0516065cffPharma Surgeen2026-06-21T00:00:00.000Znatco receives approval from central drug standard control organisation cdsco for semaglutide in indiahttps://www.pharmaradar360.com/article/natco-pharma-limited-api-unit-in-chennai-receives-establishment-inspection-repor-42d793c706edb7c4Pharma Surgeen2026-06-21T00:00:00.000Znatco pharma limited api unit in chennai receives establishment inspection report eir from u s fdahttps://www.pharmaradar360.com/article/natco-pharma-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-ce458275a03dff91Pharma Surgeen2026-06-21T00:00:00.000Znatco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290https://www.pharmaradar360.com/article/natco-announces-launch-of-pomalidomide-capsules-generic-of-pomalyst-in-the-u-s-m-794f7d2e07d1da05Pharma Surgeen2026-06-21T00:00:00.000Znatco announces launch of pomalidomide capsules generic of pomalyst in the u s markethttps://www.pharmaradar360.com/article/natco-announces-launch-of-its-everolimus-tablets-1-mg-generic-of-zortress-0fbd3eb6bfd79f71Pharma Surgeen2026-06-21T00:00:00.000Znatco announces launch of its everolimus tablets 1 mg generic of zortresshttps://www.pharmaradar360.com/article/natco-and-lupin-receive-approval-from-u-s-fda-for-eribulin-mesylate-injection-b769ec0f8c5ca64cPharma Surgeen2026-06-21T00:00:00.000Znatco and lupin receive approval from u s fda for eribulin mesylate injectionhttps://www.pharmaradar360.com/article/intimation-under-regulation-30-of-sebi-listing-obligations-and-disclosure-requir-c0cda4c720682d13Pharma Surgeen2026-06-21T00:00:00.000Zintimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2https://www.pharmaradar360.com/article/disclosure-under-regulation-30-of-the-sebi-listing-obligations-and-disclosure-re-0faab8e5df429e88Pharma Surgeen2026-06-21T00:00:00.000Zdisclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015https://www.pharmaradar360.com/article/adcock-ingram-completes-delisting-from-jse-natco-pharma-acquires-35-75-stake-4877e57849762c15Pharma Surgeen2026-06-21T00:00:00.000Zadcock ingram completes delisting from jse natco pharma acquires 35 75 stakehttps://www.pharmaradar360.com/article/home-page-1babce4bc68236c6Pharma Surgeen2026-06-21T00:00:00.000ZHome pagehttps://www.pharmaradar360.com/article/scientists-found-a-cannabis-compound-that-relieves-pain-without-the-high-40735f2b86392634Pharma Surgeen2026-06-20T15:33:51.000ZScientists found a cannabis compound that relieves pain without the highhttps://www.pharmaradar360.com/article/this-dna-repair-gene-went-rogue-and-exposed-a-cancer-weakness-c06077b5d7503918Pharma Surgeen2026-06-20T12:27:35.000ZThis DNA repair gene went rogue and exposed a cancer weaknesshttps://www.pharmaradar360.com/article/ozempic-changed-obesity-treatment-but-experts-say-the-real-revolution-is-next-9ec9bda307a8dbfcPharma Surgeen2026-06-20T11:28:46.000ZOzempic changed obesity treatment, but experts say the real revolution is nexthttps://www.pharmaradar360.com/article/subcutaneous-versus-transvenous-implantable-cardioverter-defibrillators-in-end-s-5fdb224a651b3c6cPharma Surgeen2026-06-20T07:39:39.000ZSubcutaneous Versus Transvenous Implantable Cardioverter‐Defibrillators in End‐Stage Renal Disease: A Real‐World Studyhttps://www.pharmaradar360.com/article/focal-activations-detected-by-an-automated-mapping-system-insights-from-contrala-c41d9495cbfbd2f2Pharma Surgeen2026-06-20T07:36:52.000ZFocal Activations Detected by an Automated Mapping System: Insights From Contralateral Atrial Burst Pacinghttps://www.pharmaradar360.com/article/first-experience-with-extravascular-implantable-cardioverter-defibrillator-under-4eae81a0f251fb53Pharma Surgeen2026-06-20T07:00:00.000ZFirst Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedationhttps://www.pharmaradar360.com/article/therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver-alterations-asco-liv-c8c509e4442e2a86Pharma Surgeen2026-06-20T07:00:00.000ZTherapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.1https://www.pharmaradar360.com/article/therapy-for-stage-iv-non-small-cell-lung-cancer-without-driver-alterations-asco-fa729545754d224ePharma Surgeen2026-06-20T07:00:00.000ZTherapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1https://www.pharmaradar360.com/article/lessons-from-gbm-agile-s-regorafenib-experience-in-newly-diagnosed-and-recurrent-a2691796a2c41276Pharma Surgeen2026-06-20T07:00:00.000ZLessons From GBM AGILE's Regorafenib Experience in Newly Diagnosed and Recurrent Glioblastomahttps://www.pharmaradar360.com/article/long-term-efficacy-and-safety-of-taletrectinib-in-patients-with-ros1-non-small-c-2d8d5b2983621c9fPharma Surgeen2026-06-20T07:00:00.000ZLong-Term Efficacy and Safety of Taletrectinib in Patients With ROS1+ Non–Small Cell Lung Cancer: Results From the Phase II TRUST-I Studyhttps://www.pharmaradar360.com/article/reply-to-treatment-switching-and-subsequent-therapy-confound-overall-survival-es-f7b548b4462b512dPharma Surgeen2026-06-20T07:00:00.000ZReply to: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROShttps://www.pharmaradar360.com/article/reply-to-signal-worth-trusting-if-we-can-reproduce-it-clarifying-overall-respons-1d076353514f8771Pharma Surgeen2026-06-20T07:00:00.000ZReply to: Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immunohttps://www.pharmaradar360.com/article/menopausal-hormone-therapy-after-breast-cancer-personalization-not-prohibition-6c7ef606352e6cd3Pharma Surgeen2026-06-20T07:00:00.000ZMenopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibitionhttps://www.pharmaradar360.com/article/cracks-in-the-estrogen-carcinogenesis-of-breast-cancer-fc65f1bac5694641Pharma Surgeen2026-06-20T07:00:00.000ZCracks in the Estrogen Carcinogenesis of Breast Cancerhttps://www.pharmaradar360.com/article/signal-worth-trusting-if-we-can-reproduce-it-clarifying-overall-response-rate-an-10c782472bb13067Pharma Surgeen2026-06-20T07:00:00.000ZSignal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immunohttps://www.pharmaradar360.com/article/multicenter-randomized-phase-ii-trial-of-olaparib-plus-radium-223-versus-radium-68cb1b45f4ed21d7Pharma Surgeen2026-06-20T07:00:00.000ZMulticenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)https://www.pharmaradar360.com/article/treatment-switching-and-subsequent-therapy-confound-overall-survival-estimates-i-0a1f9feab7c0d141Pharma Surgeen2026-06-20T07:00:00.000ZTreatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROShttps://www.pharmaradar360.com/article/expert-opinion-on-the-diagnosis-and-treatment-of-hematologic-malignancies-during-651d3c6f62e7de6cPharma Surgeen2026-06-20T07:00:00.000ZExpert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During Pregnancyhttps://www.pharmaradar360.com/article/neoadjuvant-single-cycle-pembrolizumab-for-stage-i-iii-mmr-deficient-colon-cance-9b6bcc718272c052Pharma Surgeen2026-06-20T07:00:00.000ZNeoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trialhttps://www.pharmaradar360.com/article/ficerafusp-alfa-bca101-with-pembrolizumab-for-recurrent-or-metastatic-head-and-n-f47be6df5da460a3Pharma Surgeen2026-06-20T07:00:00.000ZFicerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trialhttps://www.pharmaradar360.com/article/evaluation-of-regorafenib-in-newly-diagnosed-and-recurrent-glioblastoma-gbm-agil-30741e411920454bPharma Surgeen2026-06-20T07:00:00.000ZEvaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trialhttps://www.pharmaradar360.com/article/malignant-adult-ovarian-germ-cell-tumors-an-international-multicenter-study-to-i-ff91fb7f41cde9a0Pharma Surgeen2026-06-20T07:00:00.000ZMalignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyondhttps://www.pharmaradar360.com/article/glucocorticoid-and-mitophagy-signaling-based-molecular-subtyping-reveals-hmga1-a-c72453d7c1024a5aPharma Surgeen2026-06-20T00:00:00.000ZGlucocorticoid and mitophagy signaling–based molecular subtyping reveals HMGA1 as a prognostic and immunotherapy biomarker in lung adenocarcinomahttps://www.pharmaradar360.com/article/sgi-7079-as-a-novel-type-i-flt3-inhibitor-overcomes-resistance-to-gilteritinib-a-b9628db115a3379fPharma Surgeen2026-06-20T00:00:00.000ZSGI-7079 as a novel type I FLT3 inhibitor overcomes resistance to gilteritinib and quizartinib mediated by ITD and TKD mutations in acute myeloid leukemiahttps://www.pharmaradar360.com/article/hmgb3-facilitates-malignant-phenotype-of-esophageal-carcinoma-via-histone-lactyl-c0c1aa6f269a7e73Pharma Surgeen2026-06-20T00:00:00.000ZHMGB3 facilitates malignant phenotype of esophageal carcinoma via histone lactylation- and Wnt/β-catenin-dependent transcription activation of c-mychttps://www.pharmaradar360.com/article/clinical-responses-to-trastuzumab-deruxtecan-in-molecularly-defined-ependymoma-c573925998b5e35cPharma Surgeen2026-06-20T00:00:00.000ZClinical responses to trastuzumab deruxtecan in molecularly defined ependymomahttps://www.pharmaradar360.com/article/la-ricerca-di-policlinico-di-milano-universita-degli-studi-di-milano-protagonist-c238d3c23fd4bef3Pharma Surgeen2026-06-19T22:24:00.000ZLa ricerca di Policlinico di Milano-Università degli Studi di Milano protagonista all’European Hematology Associationhttps://www.pharmaradar360.com/article/alfredo-gaete-asume-la-direccion-del-campus-villarrica-con-foco-en-el-territorio-63ecc5aacf196877Pharma Surgeen2026-06-19T19:11:55.000ZAlfredo Gaete asume la dirección del campus Villarrica con foco en el territoriohttps://www.pharmaradar360.com/article/asco-2026-next-generation-immunotherapies-16e02b4d6d688f57Pharma Surgeen2026-06-19T18:44:28.000ZASCO 2026: Next-Generation Immunotherapieshttps://www.pharmaradar360.com/article/art-show-features-work-from-45-student-artists-34b172110e0431caPharma Surgeen2026-06-19T17:52:20.000ZArt show features work from 45 student artistshttps://www.pharmaradar360.com/article/on-behalf-of-respighi-bidco-s-p-a-press-release-pursuant-to-article-38-paragraph-8637762fcce8990fPharma Surgeen2026-06-19T17:49:09.000ZOn behalf of Respighi BidCo S.p.A – Press Release pursuant to Article 38, paragraph 1, of the Issuers’ Regulation – Suspension of the review periodhttps://www.pharmaradar360.com/article/college-world-series-means-special-father-s-day-for-carolina-coach-family-1a4fe4c6c037eedcPharma Surgeen2026-06-19T17:34:58.000ZCollege World Series means special Father’s Day for Carolina coach, familyhttps://www.pharmaradar360.com/article/this-fan-worked-for-crawdads-panthers-and-bulls-d3bf19df14428f8fPharma Surgeen2026-06-19T17:34:41.000ZThis fan worked for Crawdads, Panthers and Bullshttps://www.pharmaradar360.com/article/resultados-del-ranking-qs-destacan-fortalecimiento-de-la-experiencia-formativa-e-57330615198b2eeePharma Surgeen2026-06-19T17:26:16.000ZResultados del ranking QS destacan fortalecimiento de la experiencia formativa en la UChttps://www.pharmaradar360.com/article/mmi-partners-with-joslyn-castle-to-staff-carriage-house-cafe-6fdc76ff349f30caPharma Surgeen2026-06-19T16:58:57.000ZMMI partners with Joslyn Castle to staff Carriage House Cafehttps://www.pharmaradar360.com/article/anmat-fortalece-su-capacidad-de-referencia-regional-en-el-control-de-vacunas-ant-dacdc46d441bbe86Pharma Surgeen2026-06-19T16:48:38.000ZANMAT fortalece su capacidad de referencia regional en el control de vacunas antigripaleshttps://www.pharmaradar360.com/article/garden-walk-draws-thousands-for-good-cause-6be9e41e5e38719bPharma Surgeen2026-06-19T16:46:19.000ZGarden Walk draws thousands for good causehttps://www.pharmaradar360.com/article/medhealth-outlook-altasciences-drug-development-that-is-faster-by-design-28f42083774a4d7bPharma Surgeen2026-06-19T16:38:12.000ZMedhealth Outlook: Altasciences - Drug Development That is Faster by Designhttps://www.pharmaradar360.com/article/mmi-voices-occupational-therapy-summer-camps-offer-fun-friendship-and-skill-buil-28edb7421eea5869Pharma Surgeen2026-06-19T16:19:37.000ZMMI Voices: Occupational therapy summer camps offer fun, friendship and skill buildinghttps://www.pharmaradar360.com/article/pharmaceutical-executive-daily-fda-advisory-committee-votes-unanimously-in-favor-e4933408b042bd66Pharma Surgeen2026-06-19T16:04:37.000ZPharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010https://www.pharmaradar360.com/article/la-unlp-consolida-su-lugar-a-nivel-nacional-y-se-mantiene-entre-las-mejores-del-7ec125b6acedd896Pharma Surgeen2026-06-19T15:50:51.000ZLa UNLP consolida su lugar a nivel nacional y se mantiene entre las mejores del mundo en el ranking QShttps://www.pharmaradar360.com/article/homenaje-a-la-bandera-en-los-jardines-del-rectorado-8326c312b5ac6204Pharma Surgeen2026-06-19T15:50:11.000ZHomenaje a la Bandera en los jardines del Rectoradohttps://www.pharmaradar360.com/article/signing-in-to-mychart-with-your-nhs-login-55dd9efea79e578ePharma Surgeen2026-06-19T15:49:45.000ZSigning in to MyChart with your NHS loginhttps://www.pharmaradar360.com/article/ai-readiness-in-pharma-getting-the-foundation-right-709c81fe69ec3e32Pharma Surgeen2026-06-19T15:20:37.000ZAI Readiness in Pharma – Getting the Foundation Righthttps://www.pharmaradar360.com/article/prof-dr-matthias-guckenberger-ubergibt-estro-prasidentschaft-e4ade8f3e426a8b8Pharma Surgeen2026-06-19T15:01:40.000ZProf. Dr. Matthias Guckenberger übergibt ESTRO-Präsidentschafthttps://www.pharmaradar360.com/article/wildlife-in-chornobyl-is-changing-its-behaviour-during-russian-invasion-d1c53a24c39be9faPharma Surgeen2026-06-19T14:37:34.000ZWildlife in Chornobyl is changing its behaviour during Russian invasionhttps://www.pharmaradar360.com/article/congressman-proposes-draft-legislation-to-accelerate-us-clinical-trials-d363bf1ab8cd0470Pharma Surgeen2026-06-19T14:32:26.000ZCongressman proposes draft legislation to accelerate US clinical trialshttps://www.pharmaradar360.com/article/qs-world-university-rankings-2027-the-university-of-freiburg-ranks-among-the-top-95fe9d76619c26fePharma Surgeen2026-06-19T14:30:04.000ZQS World University Rankings 2027: The University of Freiburg ranks among the top 10 nationally across several indicatorshttps://www.pharmaradar360.com/article/pharma-funding-roudup-kardigan-announces-400-million-initial-ipo-campfield-launc-f87fd6eaacec60bdPharma Surgeen2026-06-19T14:09:52.000ZPharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series Ahttps://www.pharmaradar360.com/article/think-you-re-eating-healthy-you-may-be-missing-this-heart-protecting-nutrient-0f351bb3f1252353Pharma Surgeen2026-06-19T13:56:05.000ZThink you're eating healthy? You may be missing this heart-protecting nutrienthttps://www.pharmaradar360.com/article/eye-opening-study-highlights-connection-between-hpv-and-uveitis-641f5b6f51f2f1a6Pharma Surgeen2026-06-19T13:54:42.000ZEye-opening study highlights connection between HPV and uveitishttps://www.pharmaradar360.com/article/fda-advisory-committee-votes-unanimously-in-favor-of-the-benefit-risk-profile-of-7172dd078f9e2e5aPharma Surgeen2026-06-19T13:43:05.000ZFDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010https://www.pharmaradar360.com/article/vinculaciones-municipios-unlp-2026-48704d87014cfb42Pharma Surgeen2026-06-19T13:30:47.000ZVINCULACIONES MUNICIPIOS – UNLP 2026https://www.pharmaradar360.com/article/acreditados-acreditacion-de-proyectos-i-d-y-ppid-2026-296f12611a5f13f7Pharma Surgeen2026-06-19T13:13:49.000ZAcreditados | Acreditación de Proyectos I+D y PPID 2026https://www.pharmaradar360.com/article/alert-carolina-sirens-test-to-be-held-june-23-82a958f08000d92bPharma Surgeen2026-06-19T13:09:57.000ZAlert Carolina sirens test to be held June 23https://www.pharmaradar360.com/article/universitat-heidelberg-humboldt-professur-fur-internationalen-spitzenforscher-180c8e1920a6638bPharma Surgeen2026-06-19T13:07:08.000ZUniversität Heidelberg: Humboldt-Professur für internationalen Spitzenforscherhttps://www.pharmaradar360.com/article/the-naming-patterns-behind-12-000-biotech-companies-3bfa31c6da139cd7Pharma Surgeen2026-06-19T13:00:00.000ZThe Naming Patterns Behind 12,000 Biotech Companieshttps://www.pharmaradar360.com/article/compras-y-contrataciones-75de4b64a2b8dda2Pharma Surgeen2026-06-19T12:45:04.000ZCompras y Contratacioneshttps://www.pharmaradar360.com/article/essex-partnership-digital-tool-improves-leg-wound-and-ulcer-care-1d2461036ff6049ePharma Surgeen2026-06-19T12:30:20.000ZEssex Partnership digital tool improves leg wound and ulcer carehttps://www.pharmaradar360.com/article/volontariato-22-06-cieli-azzurri-concerto-jazz-per-i-bambini-del-policlinico-di-b0a47990799375ecPharma Surgeen2026-06-19T12:00:00.000Z#VOLONTARIATO [22.06] Cieli Azzurri, concerto jazz per i bambini del Policlinico di Milanohttps://www.pharmaradar360.com/article/dna-in-neurons-is-damaged-and-repaired-during-brain-cortex-formation-32f05abae71e89bdPharma Surgeen2026-06-19T12:00:00.000ZDNA in neurons is damaged and repaired during brain cortex formationhttps://www.pharmaradar360.com/article/eu-commission-s-draft-legislation-on-pesticides-european-re-searchers-highlight-5118e4fd09fbf130Pharma Surgeen2026-06-19T11:55:06.000ZEU Commission’s draft legislation on pesticides: European re-searchers highlight the riskshttps://www.pharmaradar360.com/article/scientists-reprogram-brain-immune-cells-to-fight-alzheimer-s-0050dbc6bf29b77ePharma Surgeen2026-06-19T11:47:55.000ZScientists reprogram brain immune cells to fight Alzheimer’shttps://www.pharmaradar360.com/article/universitat-heidelberg-humboldt-professorship-for-leading-international-research-76b7402e082f54e0Pharma Surgeen2026-06-19T11:46:44.000ZUniversität Heidelberg: Humboldt Professorship for Leading International Researcherhttps://www.pharmaradar360.com/article/eu-mdr-change-control-for-samd-greenlight-guru-1472c7cf4fb5e3bePharma Surgeen2026-06-19T11:43:43.000ZEU MDR change control for SaMD | Greenlight Guruhttps://www.pharmaradar360.com/article/new-laser-system-delivers-first-experiment-3fee86eacc65bc9cPharma Surgeen2026-06-19T11:34:24.000ZNew laser system delivers first experimenthttps://www.pharmaradar360.com/article/tauber-recorrio-las-obras-finalizadas-del-primer-modulo-de-viviendas-del-barrio-8002ca76774d344ePharma Surgeen2026-06-19T11:02:44.000ZTauber recorrió las obras finalizadas del primer módulo de viviendas del barrio estudiantilhttps://www.pharmaradar360.com/article/facundo-manes-conversara-sobre-inteligencia-artificial-y-salud-cerebral-efec5228f36932eaPharma Surgeen2026-06-19T11:00:17.000ZFacundo Manes conversará sobre inteligencia artificial y salud cerebralhttps://www.pharmaradar360.com/article/researchers-caught-in-the-crossfire-as-companies-and-government-grapple-over-ai-f70612d3c2b53842Pharma Surgeen2026-06-19T11:00:00.000ZResearchers caught in the crossfire as companies and government grapple over AI safetyhttps://www.pharmaradar360.com/article/biopharma-industry-confidence-at-highest-in-years-despite-geopolitical-headwinds-a20547ecb396f6a6Pharma Surgeen2026-06-19T10:16:19.000ZBiopharma industry confidence at highest in years despite geopolitical headwindshttps://www.pharmaradar360.com/article/biopharma-industry-confidence-at-highest-in-years-despite-geopolitical-headwinds-8ec301d2ae549518Pharma Surgeen2026-06-19T10:14:21.000ZBiopharma industry confidence at highest in years despite geopolitical headwindshttps://www.pharmaradar360.com/article/redefining-obesity-success-in-the-glp-1-era-q-a-with-brian-hilberdink-665fa0da570717e7Pharma Surgeen2026-06-19T10:00:00.000ZRedefining Obesity Success in the GLP-1 Era: Q&A with Brian Hilberdinkhttps://www.pharmaradar360.com/article/additive-manufacturing-s-application-in-pharma-and-biotech-a099dc63a5b655d0Pharma Surgeen2026-06-19T10:00:00.000ZAdditive Manufacturing's Application in Pharma and Biotechhttps://www.pharmaradar360.com/article/zastuda-ta-alergiya-3ed32f222406f2d6Pharma Surgeen2026-06-19T09:37:28.000Zzastuda ta alergiyahttps://www.pharmaradar360.com/article/problemi-bolyu-9fed37c2a30a5d6aPharma Surgeen2026-06-19T09:37:28.000Zproblemi bolyuhttps://www.pharmaradar360.com/article/nevrologiya-3a7eaaf25c347fa7Pharma Surgeen2026-06-19T09:37:28.000Znevrologiyahttps://www.pharmaradar360.com/article/kardiometabolichni-fff1ab328ee5a9adPharma Surgeen2026-06-19T09:37:28.000Zkardiometabolichnihttps://www.pharmaradar360.com/article/intimne-zdorovya-32699df30e67f69ePharma Surgeen2026-06-19T09:37:28.000Zintimne zdorovyahttps://www.pharmaradar360.com/article/gastroenterologiya-d067713241bc5c81Pharma Surgeen2026-06-19T09:37:28.000Zgastroenterologiyahttps://www.pharmaradar360.com/article/dermatologiya-bbb51636f5d89a15Pharma Surgeen2026-06-19T09:37:28.000Zdermatologiyahttps://www.pharmaradar360.com/article/antibiotiki-72c23dae4072c9e6Pharma Surgeen2026-06-19T09:37:28.000Zantibiotikihttps://www.pharmaradar360.com/article/alergiia-2a920df32b6e1d60Pharma Surgeen2026-06-19T09:37:28.000Zalergiiahttps://www.pharmaradar360.com/article/usi-preparati-c49315a749707ed3Pharma Surgeen2026-06-19T09:37:28.000Zusi preparatihttps://www.pharmaradar360.com/article/shionogi-and-f2g-report-positive-top-line-data-from-phase-iii-oasis-study-c63c475b3b515f27Pharma Surgeen2026-06-19T09:36:54.000ZShionogi and F2G report positive top line data from Phase III OASIS studyhttps://www.pharmaradar360.com/article/volunteers-transform-hospital-garden-into-welcoming-outdoor-space-2f2618e4892b695ePharma Surgeen2026-06-19T09:31:23.000ZVolunteers transform hospital garden into welcoming outdoor spacehttps://www.pharmaradar360.com/article/world-cup-stadiums-almost-full-despite-high-ticket-prices-says-sports-economist-4783817d4c987cc3Pharma Surgeen2026-06-19T09:24:37.000ZWorld Cup stadiums almost full despite high ticket prices, says sports economist Thomas Peetershttps://www.pharmaradar360.com/article/supporter-runs-arctic-marathon-for-guy-s-cancer-charity-1f9c52ee2ff69173Pharma Surgeen2026-06-19T09:23:22.000ZSupporter runs Arctic marathon for Guy's Cancer Charityhttps://www.pharmaradar360.com/article/voro-and-alloy-partner-on-tumour-selective-tce-therapeutics-4313a5f22f6ce4e8Pharma Surgeen2026-06-19T09:22:14.000ZVoro and Alloy partner on tumour-selective TCE therapeuticshttps://www.pharmaradar360.com/article/maia-activates-new-site-for-thio-101-phase-ii-trial-ebbf38ce21755cccPharma Surgeen2026-06-19T09:03:10.000ZMAIA activates new site for THIO-101 Phase II trialhttps://www.pharmaradar360.com/article/biogen-to-acquire-raythera-for-up-to-1bn-89e58495b78920d6Pharma Surgeen2026-06-19T08:48:18.000ZBiogen to acquire RayThera for up to $1bnhttps://www.pharmaradar360.com/article/fda-warning-slams-zoll-medical-with-multiple-quality-control-and-reporting-viola-00a53e75c2aa7d14Pharma Surgeen2026-06-19T08:26:00.000ZFDA warning slams Zoll Medical with multiple quality control and reporting violationshttps://www.pharmaradar360.com/article/universitatsklinikum-essen-besteht-tuv-uberwachungsaudit-nach-iso-9001-erneut-er-5668cf604f7f9301Pharma Surgeen2026-06-19T08:19:47.000ZUniversitätsklinikum Essen besteht TÜV-Überwachungsaudit nach ISO 9001 erneut erfolgreichhttps://www.pharmaradar360.com/article/asco26-rlts-bring-the-buzz-but-commercial-and-tolerability-qualms-remain-4d21d89dfa4d9b7dPharma Surgeen2026-06-19T08:13:51.000ZASCO26: RLTs bring the buzz, but commercial and tolerability qualms remainhttps://www.pharmaradar360.com/article/welcome-prof-dr-fabian-michl-professor-of-public-law-ed8030584c161d19Pharma Surgeen2026-06-19T08:10:57.000ZWelcome: Prof. Dr Fabian Michl, Professor of Public Lawhttps://www.pharmaradar360.com/article/information-about-the-criminal-offence-committed-by-a-former-employee-of-the-uni-2784e3991f65878cPharma Surgeen2026-06-19T08:08:00.000ZInformation about the criminal offence committed by a former employee of the University of Freiburghttps://www.pharmaradar360.com/article/ai-lab-midjourney-investing-over-74m-to-launch-whole-body-ultrasound-screening-b-d870bdd06a2d0565Pharma Surgeen2026-06-19T08:07:09.000ZAI lab Midjourney investing over $74M to launch whole-body ultrasound screening businesshttps://www.pharmaradar360.com/article/vague-de-chaleur-activation-du-numero-vert-canicule-info-service-au-0800-06-66-6-87145c4cb2b9aa20Pharma Surgeen2026-06-19T08:03:17.000ZVague de chaleur Activation du numéro vert « Canicule info service » au 0800 06 66 66https://www.pharmaradar360.com/article/light-in-a-bottle-liquid-can-harvest-and-store-energy-from-multiple-sources-26e59b04ec5b851fPharma Surgeen2026-06-19T08:00:00.000Z‘Light in a bottle’ liquid can harvest and store energy from multiple sourceshttps://www.pharmaradar360.com/article/bio-international-convention-2026-practical-advice-from-former-evotec-ceo-werner-3edaa7e62a75379fPharma Surgeen2026-06-19T08:00:00.000ZBIO International Convention 2026: practical advice from former Evotec CEO Werner Lanthalerhttps://www.pharmaradar360.com/article/ukri-announces-new-non-executive-member-77253f55f8d7dba7Pharma Surgeen2026-06-19T07:47:27.000ZUKRI announces new non-executive memberhttps://www.pharmaradar360.com/article/interventional-work-increasingly-concentrated-among-smaller-subset-of-radiologis-5c20fc9a4761bf01Pharma Surgeen2026-06-19T07:33:42.000ZInterventional work increasingly concentrated among smaller subset of radiologistshttps://www.pharmaradar360.com/article/senate-passes-radiologist-supported-bill-to-bolster-lung-cancer-research-bc1eccc83b0ddcd7Pharma Surgeen2026-06-19T07:30:13.000ZSenate passes radiologist-supported bill to bolster lung cancer researchhttps://www.pharmaradar360.com/article/25-000-genomes-for-brain-health-18c603864a0f0c0bPharma Surgeen2026-06-19T07:30:00.000Z25,000 Genomes for Brain Healthhttps://www.pharmaradar360.com/article/universitatsklinika-legen-angebot-vor-tarifabschluss-muss-dauerhaft-finanzierbar-c9ffa6c2e98bb7ecPharma Surgeen2026-06-19T07:27:58.000ZUniversitätsklinika legen Angebot vor: „Tarifabschluss muss dauerhaft finanzierbar bleiben“https://www.pharmaradar360.com/article/balancing-benefit-and-risk-nisha-vora-on-the-science-of-pharmacovigilance-2e418fe8f156c90ePharma Surgeen2026-06-19T07:00:00.000ZBalancing benefit and risk: Nisha Vora on the science of pharmacovigilancehttps://www.pharmaradar360.com/article/fat-associated-liver-disease-plays-a-key-role-in-the-development-of-liver-cancer-20bd4f37723eba96Pharma Surgeen2026-06-19T07:00:00.000ZFat-associated liver disease plays a key role in the development of liver cancerhttps://www.pharmaradar360.com/article/an-unknown-reality-when-menstruation-worsens-food-allergy-68325f1957dbc372Pharma Surgeen2026-06-19T07:00:00.000ZAn unknown reality: when menstruation worsens food allergyhttps://www.pharmaradar360.com/article/west-midlands-nhs-imaging-programme-enters-procurement-f51281be71511422Pharma Surgeen2026-06-19T06:30:28.000ZWest Midlands NHS imaging programme enters procurementhttps://www.pharmaradar360.com/article/ssc-meets-to-discuss-kemri-in-the-new-era-13ddfaefc097c42dPharma Surgeen2026-06-19T06:30:18.000ZSSC Meets to Discuss “KEMRI in the New Era”https://www.pharmaradar360.com/article/iga-0ac17d5f6974c58fPharma Surgeen2026-06-19T06:30:02.000Zスパルセンタン、IgA腎症に対し国内で製造販売承認申請https://www.pharmaradar360.com/article/chugai-files-new-drug-application-in-japan-for-sparsentan-for-the-treatment-of-i-16c6fbd77c85b28cPharma Surgeen2026-06-19T06:30:02.000ZChugai Files New Drug Application in Japan for Sparsentan for the Treatment of IgA Nephropathyhttps://www.pharmaradar360.com/article/2-24a322bc5ae3c0a0Pharma Surgeen2026-06-19T06:30:01.000Zアバスチン、神経線維腫症2型に対する世界初の治療薬として、適応追加の承認を取得https://www.pharmaradar360.com/article/avastin-receives-approval-for-additional-indication-as-the-world-rsquo-s-first-t-a590b741b118683cPharma Surgeen2026-06-19T06:30:01.000ZAvastin Receives Approval for Additional Indication as the World’s First Treatment for Neurofibromatosis Type 2https://www.pharmaradar360.com/article/cd20-reg-4ef5716640e6ea7bPharma Surgeen2026-06-19T06:30:00.000Z抗CD20モノクローナル抗体「リツキサン®」成人期発症の頻回再発型あるいはステロイド依存性のネフローゼ症候群に対する承認取得についてhttps://www.pharmaradar360.com/article/anti-cd20-monoclonal-antibody-rituxan-reg-approved-for-adult-onset-frequently-re-808773305281a197Pharma Surgeen2026-06-19T06:30:00.000ZAnti-CD20 Monoclonal Antibody Rituxan® Approved for Adult-onset Frequently Relapsing or Steroid-dependent Nephrotic Syndromehttps://www.pharmaradar360.com/article/the-ars-legendi-faculty-award-for-excellence-in-teaching-medicine-2026-for-goes-b8d51b52b3327688Pharma Surgeen2026-06-19T06:17:00.000ZThe Ars Legendi faculty award for excellence in teaching medicine 2026 for goes to Dr. Götz Fabryhttps://www.pharmaradar360.com/article/epigenetische-therapie-neue-hoffnung-fur-gefasse-bei-diabetes-und-adipositas-64aca0356ff97f5fPharma Surgeen2026-06-19T06:10:49.000ZEpigenetische Therapie: Neue Hoffnung für Gefässe bei Diabetes und Adipositashttps://www.pharmaradar360.com/article/ac7724329b6e92f2Pharma Surgeen2026-06-19T06:00:36.000ZΔήλωση Αποθεμάτων Φαρμάκων Ανθρώπινης Χρήσηςhttps://www.pharmaradar360.com/article/this-giant-tropical-fruit-could-help-reverse-gum-disease-damage-0947cee0fa8bb636Pharma Surgeen2026-06-19T05:59:41.000ZThis giant tropical fruit could help reverse gum disease damagehttps://www.pharmaradar360.com/article/formazione-19-06-l-anziano-tra-fisiologia-e-patologia-immunosenescenza-57fec9db05248bc6Pharma Surgeen2026-06-19T05:36:00.000Z#FORMAZIONE. [19.06] L'anziano tra fisiologia e patologia. Immunosenescenzahttps://www.pharmaradar360.com/article/wegovy-subcutaneous-injection-co-promoted-with-novo-nordisk-pharma-approved-in-j-06f471360697f730Pharma Surgeen2026-06-19T05:00:00.000ZWegovy Subcutaneous Injection, Co-Promoted with Novo Nordisk Pharma, Approved in Japan for Metabolic Dysfunction-Associated Steatohepatitis (MASH)https://www.pharmaradar360.com/article/new-european-initiative-to-accelerate-drug-discovery-for-cardiometabolic-disease-e55dbf067e804d7ePharma Surgeen2026-06-19T05:00:00.000ZNew European initiative to accelerate drug discovery for cardiometabolic diseaseshttps://www.pharmaradar360.com/article/2025-90805-1223-2009-c69cdb06e2a833bbPharma Surgeen2026-06-19T03:43:08.000ZΑΝΑΚΟΙΝΩΣΗ ΣΧΕΤΙΚΑ ΜΕ ΔΙΟΡΘΩΤΙΚΟ 2025/90805 ΣΤΟΝ ΚΑΝΟΝΙΣΜΟ 1223/2009https://www.pharmaradar360.com/article/ibento-ibento-the-report-for-the-pmda-asia-office-gcp-workshop-2026-has-been-pos-97fd450d5defa28dPharma Surgeen2026-06-19T03:00:00.000Z[IBENTO][IBENTO]The report for the PMDA Asia office GCP workshop 2026 has been posted.https://www.pharmaradar360.com/article/ibento-ibento-the-report-for-the-pmda-asia-office-gmp-workshop-training-2026-has-cf04afbdc32bba1bPharma Surgeen2026-06-19T03:00:00.000Z[IBENTO][IBENTO]The report for the PMDA Asia office GMP Workshop Training 2026 has been posted.https://www.pharmaradar360.com/article/scientists-may-have-found-what-really-triggers-alzheimer-s-disease-4596ebd377209a3aPharma Surgeen2026-06-19T02:49:38.000ZScientists May Have Found What Really Triggers Alzheimer’s Diseasehttps://www.pharmaradar360.com/article/8cb401fca675637cPharma Surgeen2026-06-19T02:20:18.000Z脂肪由来のホルモン「アディポネクチン」の カロリー制限時の働きを明らかに―アディポネクチンの機能は食事条件と性別に依存する―https://www.pharmaradar360.com/article/2026-4-7-16-72c2ccea7d2f2de3Pharma Surgeen2026-06-19T01:17:51.000Z2026年度 第4回東北大学病院がんセミナー開催のお知らせ（7/16開催）https://www.pharmaradar360.com/article/estudian-el-impacto-del-calentamiento-global-en-las-comunidades-microbianas-del-ac960ee56abb42caPharma Surgeen2026-06-19T00:22:05.000ZEstudian el impacto del calentamiento global en las comunidades microbianas del suelo antárticohttps://www.pharmaradar360.com/article/santen-obtains-manufacturing-and-marketing-approval-in-japan-for-rhopressa-ophth-3ab34ee7e24a5670Pharma Surgeen2026-06-19T00:00:00.000ZSanten Obtains Manufacturing and Marketing Approval in Japan for Rhopressa® Ophthalmic Solution 0.02%, a Treatment for Glaucoma and Ocular Hypertensionhttps://www.pharmaradar360.com/article/sequence-specific-targeting-of-vegfa-genomic-dna-to-inhibit-tumor-growth-33a45816bd745dd6Pharma Surgeen2026-06-19T00:00:00.000ZSequence-specific targeting of VEGFA genomic DNA to inhibit tumor growthhttps://www.pharmaradar360.com/article/a-fatty-acid-amide-activates-myeloid-cells-and-improves-neurovascular-outcomes-i-791a7dd0cb8b1728Pharma Surgeen2026-06-19T00:00:00.000ZA fatty acid amide activates myeloid cells and improves neurovascular outcomes in retinal degenerationhttps://www.pharmaradar360.com/article/voltage-dynamics-of-cortical-dendrites-in-vivo-8d84d95a6800c639Pharma Surgeen2026-06-19T00:00:00.000ZVoltage dynamics of cortical dendrites in vivohttps://www.pharmaradar360.com/article/tryptamine-from-wake-active-monoaminergic-neurons-regulates-sleep-homeostasis-a35a2f1a951f4beePharma Surgeen2026-06-19T00:00:00.000ZTryptamine from wake-active monoaminergic neurons regulates sleep homeostasishttps://www.pharmaradar360.com/article/author-correction-mage-a4-mage-a8-targeted-tcr-based-bispecific-t-cell-engager-i-0cd078a1e77903d8Pharma Surgeen2026-06-19T00:00:00.000ZAuthor Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trialhttps://www.pharmaradar360.com/article/optimized-r2-retroelement-complexes-for-dna-insertion-into-plant-genomes-f88b4bdbee171a09Pharma Surgeen2026-06-19T00:00:00.000ZOptimized R2 retroelement complexes for DNA insertion into plant genomeshttps://www.pharmaradar360.com/article/efficient-site-specific-gene-addition-using-r2-retrotransposons-in-tobacco-and-r-f63f4d6c18fc339ePharma Surgeen2026-06-19T00:00:00.000ZEfficient site-specific gene addition using R2 retrotransposons in tobacco and ricehttps://www.pharmaradar360.com/article/author-correction-autophagic-cell-death-restricts-chromosomal-instability-during-51050cc29d6c1d04Pharma Surgeen2026-06-19T00:00:00.000ZAuthor Correction: Autophagic cell death restricts chromosomal instability during replicative crisishttps://www.pharmaradar360.com/article/briefing-chat-testosterone-and-sperm-might-get-a-boost-from-obesity-drugs-c53ed95a519900d0Pharma Surgeen2026-06-19T00:00:00.000ZBriefing Chat: Testosterone and sperm might get a boost from obesity drugshttps://www.pharmaradar360.com/article/a-long-lived-butterfly-s-secret-to-graceful-ageing-cb46d31e876d2dddPharma Surgeen2026-06-19T00:00:00.000ZA long-lived butterfly’s secret to graceful ageinghttps://www.pharmaradar360.com/article/stem-cells-banish-severe-autoimmune-disease-for-15-years-5b5c312f306cc7abPharma Surgeen2026-06-19T00:00:00.000ZStem cells banish severe autoimmune disease for 15 yearshttps://www.pharmaradar360.com/article/eyes-to-the-sky-the-many-benefits-of-bird-watching-aa2d205d3af0a561Pharma Surgeen2026-06-19T00:00:00.000ZEyes to the Sky: The Many Benefits of Bird Watchinghttps://www.pharmaradar360.com/article/driving-simulator-helps-mom-who-suffered-stroke-get-back-on-road-f55efa1d2307bb22Pharma Surgeen2026-06-19T00:00:00.000ZDriving Simulator Helps Mom Who Suffered Stroke Get Back on Roadhttps://www.pharmaradar360.com/article/dad-back-to-racing-after-kidney-transplant-battle-with-cancer-e17711e0641c1a56Pharma Surgeen2026-06-19T00:00:00.000ZDad Back to Racing After Kidney Transplant, Battle with Cancerhttps://www.pharmaradar360.com/article/photo-quiz-parasite-eggs-detected-by-ai-are-not-always-what-they-are-cracked-up-78451eaca3780b90Pharma Surgeen2026-06-18T22:31:33.000ZPhoto Quiz: Parasite eggs detected by AI are not always what they are cracked up to behttps://www.pharmaradar360.com/article/passaparola-emergenza-caldo-2026-come-proteggersi-dalle-ondate-di-calore-a20b4e278d23ad6bPharma Surgeen2026-06-18T22:29:00.000Z#PASSAPAROLA. Emergenza Caldo 2026 - Come proteggersi dalle ondate di calorehttps://www.pharmaradar360.com/article/a-6-month-pre-and-post-implementation-analysis-of-ai-augmented-screening-of-conc-8e838cc4352b852dPharma Surgeen2026-06-18T22:28:03.000ZA 6-month pre- and post-implementation analysis of AI-augmented screening of concentrated fecal wet mounts